These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2246236)

  • 1. Characterization of the receptors for vascular endothelial growth factor.
    Vaisman N; Gospodarowicz D; Neufeld G
    J Biol Chem; 1990 Nov; 265(32):19461-6. PubMed ID: 2246236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
    Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
    J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of vascular permeability factor to endothelial cells.
    Olander JV; Connolly DT; DeLarco JE
    Biochem Biophys Res Commun; 1991 Feb; 175(1):68-76. PubMed ID: 1998521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells.
    Thieme H; Aiello LP; Takagi H; Ferrara N; King GL
    Diabetes; 1995 Jan; 44(1):98-103. PubMed ID: 7529203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
    Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
    Soker S; Svahn CM; Neufeld G
    J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment.
    Friesel R; Burgess WH; Mehlman T; Maciag T
    J Biol Chem; 1986 Jun; 261(17):7581-4. PubMed ID: 3519611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.
    Gitay-Goren H; Halaban R; Neufeld G
    Biochem Biophys Res Commun; 1993 Feb; 190(3):702-8. PubMed ID: 8439321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
    J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of heparin-binding growth-associated factor receptor on NIH 3T3 cells.
    Kuo MD; Huang SS; Huang JS
    Biochem Biophys Res Commun; 1992 Jan; 182(1):188-94. PubMed ID: 1731778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
    Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
    Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes.
    Takagi H; King GL; Aiello LP
    Diabetes; 1996 Aug; 45(8):1016-23. PubMed ID: 8690146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.
    Chakraborty I; Das SK; Dey SK
    J Endocrinol; 1995 Nov; 147(2):339-52. PubMed ID: 7490564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J; Mayr U; Frank H; Hombach V
    J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.